|
1
|
Criqui-Filipe P, Ducret C, Maira SM and
Wasylyk B: Net, a negative Ras-switchable TCF, contains a second
inhibition domain, the CID, that mediates repression through
interactions with CtBP and de-acetylation. EMBO J. 18:3392–3403.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giovane A, Pintzas A, Maira SM,
Sobieszczuk P and Wasylyk B: Net, a new ets transcription factor
that is activated by Ras. Genes Dev. 8:1502–1513. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maira SM, Wurtz JM and Wasylyk B: Net
(ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory
domain with resemblance to the helix-loop-helix motif. EMBO J.
15:5849–5865. 1996.PubMed/NCBI
|
|
4
|
Ayadi A, Zheng H, Sobieszczuk P,
Buchwalter G, Moerman P, Alitalo K and Wasylyk B: Net-targeted
mutant mice develop a vascular phenotype and up-regulate egr-1.
EMBO J. 20:5139–5152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nozaki M, Onishi Y, Kanno N, Ono Y and
Fujimura Y: Molecular cloning of Elk-3, a new member of the Ets
family expressed during mouse embryogenesis and analysis of its
transcriptional repression activity. DNA Cell Biol. 15:855–862.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng H, Wasylyk C, Ayadi A, Abecassis J,
Schalken JA, Rogatsch H, Wernert N, Maira SM, Multon MC and Wasylyk
B: The transcription factor Net regulates the angiogenic switch.
Genes Dev. 17:2283–2297. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ducret C, Maira SM, Dierich A and Wasylyk
B: The net repressor is regulated by nuclear export in response to
anisomycin, UV, and heat shock. Mol Cell Biol. 19:7076–7087. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen ST, Pan TL, Juan HF, Chen TY, Lin YS
and Huang CM: Breast tumor microenvironment: Proteomics highlights
the treatments targeting secretome. J Proteome Res. 7:1379–1387.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Funasaka T and Raz A: The role of
autocrine motility factor in tumor and tumor microenvironment.
Cancer Metastasis Rev. 26:725–735. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tredan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yong LC and Jones BE: A comparative study
of cultured vascular and lymphatic endothelium. Exp Pathol.
42:11–25. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heo SH and Cho JY: ELK3 suppresses
angiogenesis by inhibiting the transcriptional activity of ETS-1 on
MT1-MMP. Int J Biol Sci. 10:438–447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park KS, Cha Y, Kim CH, Ahn HJ, Kim D, Ko
S, Kim KH, Chang MY, Ko JH, Noh YS, et al: Transcription elongation
factor Tcea3 regulates the pluripotent differentiation potential of
mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway. Stem
Cells. 31:282–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnson GL and Nakamura K: The c-jun
kinase/stress-activated pathway: Regulation, function, and role in
human disease. Biochim Biophys Acta. 1773:1341–1348. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gavard J: Endothelial permeability and
VE-cadherin: A wacky comradeship. Cell Adh Migr. 8:158–164. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lilien J and Balsamo J: The regulation of
cadherin-mediated adhesion by tyrosine
phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell
Biol. 17:459–465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monaghan-Benson E and Burridge K: The
regulation of vascular endothelial growth factor-induced
microvascular permeability requires Rac and reactive oxygen
species. J Biol Chem. 284:25602–25611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Winter MC, Shasby S and Shasby DM:
Compromised E-cadherin adhesion and epithelial barrier function
with activation of G protein-coupled receptors is rescued by Y-to-F
mutations in beta-catenin. Am J Physiol Lung Cell Mol Physiol.
294:L442–L448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Timmerman I, Hoogenboezem M, Bennett AM,
Geerts D, Hordijk PL and van Buul JD: The tyrosine phosphatase SHP2
regulates recovery of endothelial adherens junctions through
control of β-catenin phosphorylation. Mol Biol Cell. 23:4212–4225.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shayan R, Achen MG and Stacker SA:
Lymphatic vessels in cancer metastasis: Bridging the gaps.
Carcinogenesis. 27:1729–1738. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao Y: Opinion: Emerging mechanisms of
tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer.
5:735–743. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshimatsu Y, Yamazaki T, Mihira H, Itoh
T, Suehiro J, Yuki K, Harada K, Morikawa M, Iwata C, Minami T, et
al: Ets family members induce lymphangiogenesis through physical
and functional interaction with Prox1. J Cell Sci. 124:2753–2762.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sukriti S, Tauseef M, Yazbeck P and Mehta
D: Mechanisms regulating endothelial permeability. Pulm Circ.
4:535–551. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arima M, Cui D, Kimura T, Sonoda KH,
Ishibashi T, Matsuda S and Ikeda E: Basigin can be a therapeutic
target to restore the retinal vascular barrier function in the
mouse model of diabetic retinopathy. Sci Rep. 6:384452016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Coso S, Zeng Y, Opeskin K and Williams ED:
Vascular endothelial growth factor receptor-3 directly interacts
with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
PLoS One. 7:e395582012. View Article : Google Scholar : PubMed/NCBI
|
